Category: Penny Stock NewsSort
Mabwe Minerals, Inc. (MBMI) Lined Up for Major Production at Dodge Mine
GlobalWise Investments, Inc. (GWIV) Uses the Cloud to Bring Technologies Together
As one new technological direction after another is spawned, one thing is becoming clear: It is the combination of new technologies that results in the greatest change. Cloud technology is a prime example of this fact, since it is integrated with, or even enables, many other technologies. One of the greatest benefits of cloud-based applications is the ability to access both data and functionality anywhere and anytime. This leads, naturally, to a strong relationship with mobile device technology, a symbiotic relationship that encourages both cloud and mobile developments.
Advaxis, Inc. (ADXS) Submits Request for Orphan Drug Designation
Today, Advaxis, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, reported the submission of an application for Orphan Drug Designation with the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus (HPV)-associated head and neck cancer. It is currently estimated that there are 50,000 new cases of head and neck cancer annually, with about 15,000 deaths.
The Aristocrat Group Corp. (ASCC) Outlines Vodka Distribution Strategy
Today before the opening bell, the Aristocrat Group announced that it will be handling the distribution of its two new vodka brands through the wholly owned subsidiary TOP Shelf Distributing. This move was made to maximize profit potential in the booming $21.3 billion U.S. spirits industry.
Advaxis, Inc. (ADXS) Encourages Shareholders to Vote in Favor of Proposals 2 and 3
Advaxis, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, earlier today issued a letter to stockholders recommending that they vote ‘FOR’ Proposals No. 2 and No. 3 of its definitive proxy statement on Schedule 14A as filed with the SEC. The letter provides shareholders with compelling reasons why these proposals are in their best interests.
The full text of the letter follows:
Dear Fellow Stockholders,
Rainbow Coral Corp. (RBCC) Pursues Expansion and Explores New Funding
Advaxis, Inc. (ADXS) Files for Orphan Drug Designation for ADXS-HPV Candidate
Advaxis, a clinical-stage biotech company focused on developing the next generation of immunotherapies for cancer and infectious diseases, has submitted an application for Orphan Drug Designation with the U.S. Food and Drug Administration (FDA) Office for ADXS-HPV, the company’s lead drug candidate for the treatment of invasive cervical cancer.
“We are optimistic about our request for Orphan Drug Designation for ADXS-HPV in the indication of invasive cervical cancer,” Dr. Robert Petit, chief scientific officer of Advaxis stated in the press release.
StreamTrack, Inc. (STTK) Offers Products, Services with Global Reach
June 7th, 2013 StreamTrack is a digital media and technology services company providing audio and video streaming and advertising services through its RadioLoyalty™ platform – the company’s target market is Internet and terrestrial radio stations, Internet radio guides, and other broadcast content providers worldwide.
The company is also continuing its development of WatchThis™, a patent-pending technology that will provide Web, mobile and IP television streaming services that are e-commerce enabled within streamed content.